| Name | Title | Contact Details |
|---|
Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.
Althea Technologies, Inc., based in San Diego, CA, is focused on reducing the time, risk, and overall cost of our partner's drug development efforts. We apply immediate resources, unsurpassed scientific expertise, and a vast knowledge of regulatory
Pyramid HealthCare provides on-site Rehabilitation to individuals whose level of independence is threatened by physical injury or illness. Assessment and training in functional skills by licensed Physical, Occupational and Speech Therapists helps the
Cephalon, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Malvern, PA. To find more information about Cephalon, Inc., please visit www.cephalon.com
Texas Home Health of America is a Silsbee, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.